Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07022756

Personalized Outreach for Equitable Treatment in Rheumatology

The primary goal of this study is to determine whether providing patient honoraria and/or outreach services can improve the attendance rate of appointments at an inner city rheumatology clinic in Vancouver, British Columbia.

The main question it aims to answer are:

* Does providing a financial honorarium ($20 for each follow-up appointment with completed bloodwork) improve attendance rate at an inner city rheumatology clinic? * Does providing a personalized outreach service for rheumatic diseases improve attendance rate at an inner city rheumatology clinic?

The researchers will compare providing patient honoraria to providing both honoraria and outreach services, and compare each of these to the regular appointment schedule without honoraria or outreach.

Participants will:

* Undergo randomization to receive honoraria or honoraria and outreach services together * Complete surveys about their health and understanding of their rheumatic disease at baseline, 3-month, and 6-month intervals * Visit the clinic every month for check-ups and monitoring bloodwork if they are started on immunosuppressants for their condition

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Our study aims to enhance the existing twice-monthly rheumatology clinic at the Pender Community Health Centre with a rheumatology-specific outreach service for patients with inflammatory arthritis. This service will be provided by a rheumatology subspecialty trainee under the supervision of two attending rheumatologists. This will consist of biweekly phone calls, text messages, or home visits as per the patient's preference, at times flexible to patient needs. This will be in addition to monthly in-person assessment and bloodwork monitoring with adjustment as clinically indicated by their treating rheumatologist. Outreach services will include management of medications and side effects, proactive screening for infections, coordination of rheumatologic and general healthcare with their Primary Care Provider, social service navigation, and reminders for appointments and lab monitoring. All participants will be provided with a $20 honorarium for each in-person assessment they attend as part of the study.

The investigators will aim to enroll 20 participants between July 2025 and October 2025. Participants will be randomized to either honorarium with outreach or honorarium alone arms in a 1:1 fashion, stratified by housing status (unhoused and emergency sheltered in one strata, provisionally accommodated and stably housed in the second strata).

All enrolled participants will receive a $20 honorarium for each in-person assessment with completed monitoring bloodwork as requested by the treating rheumatologist. The program will last 6 months for each patient from time of enrolment, or until a patient chooses to leave the program, whichever is sooner. At baseline, participants will complete two surveys: one on their general health status, and one specific to their rheumatic disease. At the 3-month and 6-month visits, these surveys will be repeated, and a semi-structured interview will be completed to obtain feedback on the pilot program.

The outcomes of this study will inform how rheumatologists can better care for those who live with inflammatory arthritis and are also marginalized by extreme poverty and/or housing instability. The investigators plan on disseminating and discussing results with our participants, community members, inner city physicians, and rheumatologists. If there are specific positive themes or outcomes from the study, the investigators will advocate for additional resources to permit long-term implementation and further study to confirm results, make further improvements to our program, and improve generalizability.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have a diagnosis of inflammatory arthritis secondary to an autoimmune rheumatic disease
  • Be attached to one of the Vancouver Coastal Health Community Health Centres for primary care
  • Be willing to attend in-person appointments at Pender Community Health Centre
  • Be at least 18 years of age and capable of consenting to participation
  • Be able to receive medical care in English.

Exclusion criteria

  • Have cognitive impairment or an untreated psychiatric condition that would severely impair ability to engage with outreach or treatment
  • Have no reasonably reliable method of contact (phone, email, social media, etc.)

Treatment and study plan

Honoraria

Behavioral

A $20 honorarium for each appointment attended with completed bloodwork if requested.

Outreach

Behavioral

A personalized outreach service specific for rheumatic disease.

Primary outcomes

  1. Attendance at in-person follow-up appointments

    Time frame: Cumulative over 6 months

    Adherence to in-person follow-up measured by the ratio of appointments attended to appointments scheduled.

Secondary outcomes

  1. Clinical Disease Activity Index (CDAI)

    Time frame: 3-month and 6-month intervals.

    The change in Clinical Disease Activity Index from baseline to 3-months and 6-months. The Clinical Disease Activity Index is a validated disease outcome measure in Inflammatory Arthritis ranging from 0 to 76. A higher score means a worse outcome.

  2. Patient Qualitative Feedback

    Time frame: 3-month and 6-month intervals.

    Patient qualitative feedback on the program via semi-structured interview.

  3. Patient Reported Understanding of Disease and Medications

    Time frame: 3-month and 6-month intervals.

    Patient Reported Understanding of Disease and Medications, as measured by likert scale at baseline, 3 months, and 6 months. The likert scale will range from 1 to 10, with higher scores indicating better understanding.

  4. Patient reported pain related to arthritis

    Time frame: 3-month and 6-month intervals

    Patient reported pain related to arthritis on a visual analogue scale. The visual analogue scale is a validated measure of pain in arthritis, where participants are asked to indicate their severity of pain within the previous week on a 0 to 100mm score. A score of 0 indicates "no pain", and a score of 100 indicates "worst possible pain".

Other outcomes

  1. Tender Joint Count

    Time frame: At the 6-month interval.

    Change in the number of tender joints as measured by their treating clinician on a 28-joint count basis.

  2. Swollen joint count

    Time frame: At the 6-month interval.

    Change in the number of swollen joints as measured by their treating clinician on a 28-joint count basis.

  3. Number of Emergency Department Visits During the Study Period

    Time frame: Cumulative over 6 months

    Number of Emergency Department Visits During the Study Period

  4. Number of Days in Hospital During the Study Period

    Time frame: Cumulative over 6 months

    Number of Days in Hospital During the Study Period

  5. Serious Infections

    Time frame: Cumulative over 6 months

    Number of Serious Infections Requiring Urgent Care or Emergency Department Visitation

Study contacts

Contact information is provided by the study sponsor or research team.

Chu Ming (Alec) Yu, MD

CONTACT

[email protected]

778-807-3323

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Collaborators

  • Mary Pack Arthritis Center

Registry information

Official study title

Personalized Outreach for Equitable Treatment in Rheumatology: A Randomized Controlled Trial of Patient Outreach and Honoraria in an Inner City Rheumatology Clinic

Acronym: POET-Rheum

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 15, 2025
Registry last updated
Jul 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.